[Corrigendum] Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance

By Vesci Loredana   Carollo Valeria   Roscilli Giuseppe   Aurisicchio Luigi   Ferrara Fabiana Fosca   Spagnoli Luigi   De Santis Rita  

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 602-602

Spandidos Publications

Access to resources Recommend Favorite

Preoperative Therapy as a Model for Translational Research in Breast Cancer

By Burstein Harold  

Cancer Investigation, Vol. 26, Iss. 3, 2008-03 ,pp. : 217-221

Informa Healthcare

Access to resources Recommend Favorite

Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study

By Wenzel Catharina   Hussian Dagmar   Bartsch Rupert   Pluschnig Ursula   Locker Gottfried   Rudas Margarethe   Gnant Michael   Jakesz Raimund   Zielinski Christoph   Steger Guenther  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 7, 2004-07 ,pp. : 400-404

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

By Miles David   Baselga José   Amadori Dino   Sunpaweravong Patrapim   Semiglazov Vladimir   Knott Adam   Clark Emma   Ross Graham   Swain Sandra  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 89-99

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis

By Norum J.   Olsen J. A.   Wist E. A.   Lønning P. E.  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 153-164

Informa Healthcare

Access to resources Recommend Favorite